NO20016344L - Nye polypeptider og deres DNA - Google Patents
Nye polypeptider og deres DNAInfo
- Publication number
- NO20016344L NO20016344L NO20016344A NO20016344A NO20016344L NO 20016344 L NO20016344 L NO 20016344L NO 20016344 A NO20016344 A NO 20016344A NO 20016344 A NO20016344 A NO 20016344A NO 20016344 L NO20016344 L NO 20016344L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- salts
- compounds
- present
- dna
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 208000012659 Joint disease Diseases 0.000 abstract 1
- 208000034038 Pathologic Neovascularization Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18671899 | 1999-06-30 | ||
| PCT/JP2000/004278 WO2001002564A1 (fr) | 1999-06-30 | 2000-06-29 | Nouveau polypeptide et adn de ce polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20016344D0 NO20016344D0 (no) | 2001-12-21 |
| NO20016344L true NO20016344L (no) | 2002-02-19 |
Family
ID=16193433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20016344A NO20016344L (no) | 1999-06-30 | 2001-12-21 | Nye polypeptider og deres DNA |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6797483B1 (no) |
| EP (1) | EP1191099B1 (no) |
| KR (1) | KR20020026465A (no) |
| CN (1) | CN1359421A (no) |
| AT (1) | ATE445013T1 (no) |
| AU (1) | AU5705600A (no) |
| CA (1) | CA2377791A1 (no) |
| DE (1) | DE60043106D1 (no) |
| HU (1) | HUP0201660A2 (no) |
| NO (1) | NO20016344L (no) |
| PL (1) | PL353065A1 (no) |
| WO (1) | WO2001002564A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| AU2001232967A1 (en) * | 2000-01-25 | 2001-08-07 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| AU2003250547A1 (en) * | 2002-08-05 | 2004-02-23 | Asahi Kasei Kabushiki Kaisha | Cartilage differentiation inhibiting gene |
| WO2004015078A2 (en) * | 2002-08-08 | 2004-02-19 | Nuvelo, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| ATE492292T2 (de) | 2003-04-02 | 2011-01-15 | Ares Trading Sa | Flüssige oder gefriergetrocknete pharmazeutische zusammensetzung enthaltend fsh und/oder lh, das nichtionische tensid poloxamer 188 und ein antibakterielles mittel |
| CA2526099C (en) | 2003-06-20 | 2013-02-05 | Ares Trading Sa | Freeze-dried fsh / lh formulations |
| WO2017046314A2 (en) * | 2015-09-18 | 2017-03-23 | Sanofi | Improvement of expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor protein |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA945278B (en) * | 1993-07-20 | 1996-01-19 | Boehringer Mannheim Gmbh | Melanoma-inhibiting protein |
| US6653445B1 (en) | 1997-01-21 | 2003-11-25 | Human Genome Sciences, Inc. | Human CCV polypeptides |
| AU1934999A (en) * | 1997-12-20 | 1999-07-12 | Genetics Institute Inc. | Secreted proteins and polynucleotides encoding them |
| WO2001048203A1 (fr) | 1999-12-27 | 2001-07-05 | Takeda Chemical Industries, Ltd. | Nouvelle proteine et adn associe |
| AU2001232967A1 (en) | 2000-01-25 | 2001-08-07 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| JP6623690B2 (ja) | 2015-10-30 | 2019-12-25 | 味の素株式会社 | グルタミン酸系ｌ−アミノ酸の製造法 |
-
2000
- 2000-06-29 PL PL00353065A patent/PL353065A1/xx unknown
- 2000-06-29 AT AT00942387T patent/ATE445013T1/de not_active IP Right Cessation
- 2000-06-29 CN CN00809843A patent/CN1359421A/zh active Pending
- 2000-06-29 AU AU57056/00A patent/AU5705600A/en not_active Abandoned
- 2000-06-29 WO PCT/JP2000/004278 patent/WO2001002564A1/ja not_active Ceased
- 2000-06-29 DE DE60043106T patent/DE60043106D1/de not_active Expired - Lifetime
- 2000-06-29 US US10/019,455 patent/US6797483B1/en not_active Expired - Fee Related
- 2000-06-29 CA CA002377791A patent/CA2377791A1/en not_active Abandoned
- 2000-06-29 EP EP00942387A patent/EP1191099B1/en not_active Expired - Lifetime
- 2000-06-29 KR KR1020017016470A patent/KR20020026465A/ko not_active Withdrawn
- 2000-06-29 HU HU0201660A patent/HUP0201660A2/hu unknown
-
2001
- 2001-12-21 NO NO20016344A patent/NO20016344L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL353065A1 (en) | 2003-10-06 |
| ATE445013T1 (de) | 2009-10-15 |
| DE60043106D1 (de) | 2009-11-19 |
| NO20016344D0 (no) | 2001-12-21 |
| AU5705600A (en) | 2001-01-22 |
| HUP0201660A2 (en) | 2002-08-28 |
| CA2377791A1 (en) | 2001-01-11 |
| CN1359421A (zh) | 2002-07-17 |
| WO2001002564A1 (fr) | 2001-01-11 |
| US6797483B1 (en) | 2004-09-28 |
| KR20020026465A (ko) | 2002-04-10 |
| EP1191099A4 (en) | 2002-08-07 |
| EP1191099A1 (en) | 2002-03-27 |
| EP1191099B1 (en) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60207652D1 (de) | Durch Säuregruppen disubstitierte Heteroaryl-Derivate und ihre Verwendung als Matrix Metalloproteinas Inhibitoren | |
| ATE364698T1 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
| SE9903544D0 (sv) | Novel compounds | |
| EP1450777A4 (en) | PHARMACEUTICAL COMPOSITION WITH CHALCON OR ITS DERIVATIVES FOR MATRIX METALLOPROTEINASE INHIBITORY EFFECT | |
| DK2157192T3 (da) | Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner) | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| ATE365213T1 (de) | Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern | |
| ATE337014T1 (de) | Mannose-bindungsprotein enthaltende pharmazeutische zusammensetzungen | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| BR0210358A (pt) | Inibidores da protease de hiv, composições contendo os mesmos, seus usos farmacêuticos e materiais para sua sìntese | |
| NO20021542L (no) | Nye <alfa>-aminosyresulfonylforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem | |
| NO20022285L (no) | Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| BR0314688A (pt) | Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina | |
| FR2848413B1 (fr) | Plaque d'osteosynthese pour l'osteosynthese de petits os voisins les uns des autres | |
| SE0400043D0 (sv) | New compounds | |
| DK1206484T3 (da) | Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese | |
| DE60300021D1 (de) | (S)-4-Amino-5-Chloro-2-Methoxy-N-[1-[1-(2-Tetrahydrofuryl-Carbonyl)-4-Piperidinylmethyl]-4-Piperidinyl]benzamid zur Behandlung von Magen-Darmbewegungskrankheiten | |
| BR0016742A (pt) | Compostos e composições antipicorna virais, suas aplicações farmacêuticas, e materiais para sua sìntese | |
| MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
| SE9804212D0 (sv) | Compounds | |
| SG121733A1 (en) | Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
| NO20016344D0 (no) | Nye polypeptider og deres DNA | |
| BR0211635A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer | |
| BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
| DK1196442T3 (da) | VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |